Industry seeks clarity on export scope of batch wise solvent clearance requirement

The pharmaceutical industry has reportedly sought clarification on whether CDSCO’s batch wise registration and NOC requirements for specified high risk solvents apply to export oriented manufacturing. While supporting improved input traceability, stakeholders warned that unclear scope, limited regulatory capacity and approval delays could disrupt solvent supplies, particularly for smaller manufacturers.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.